Johnson & Johnson | Healthy Company

Johnson & Johnson | Healthy Company

We lead with a culture of ethics and integrity.

Content from this campaign

Johnson & Johnson Signs a Historic Pledge to Uphold the Integrity of the Scientific Process in Developing an Investigational COVID-19 Vaccine
Recently, Johnson & Johnson announced that we, alongside eight other companies working on investigational COVID-19 vaccines, are signing a #WeStandWithScience pledge committed to upholding the integrity of the scientific process as we work towards potential global...
Sep 14, 2020 11:30 AM ET
4 Innovative Ways Johnson & Johnson Has Helped Protect the Public's Health During Outbreaks Since the Late 1800s
From epidemic masks that the company introduced during the Spanish flu pandemic to work it's doing today on an investigational COVID-19 vaccine, learn how the company has been at the forefront of safeguarding global public health for well over a century.
Sep 4, 2020 12:00 PM ET
Johnson & Johnson Named to Fast Company's 2020 Best Workplaces for Innovators List
The company is proud to have made the list for the second year in a row. From its work on an Ebola vaccine—and an investigational COVID-19 vaccine—to collaboration taking place across its Johnson & Johnson Innovation centers, we take a look at the innovative spirit that permeates the company's culture.
Aug 17, 2020 10:30 AM ET
Johnson & Johnson Earns the #3 Spot on the 2020 Gartner Supply Chain Top 25 List
The company received its highest-ever ranking on the list this year—which honors global supply chain excellence—in part for its nimble response to the COVID-19 pandemic.
Aug 12, 2020 1:00 PM ET
“I Was Working on a Potential COVID-19 Vaccine—Then My Wife Got Sick”: Meet a Researcher Whose Personal Experience Is Fueling His Fight Against the Pandemic
In late January—weeks before many people had even heard of the novel coronavirus—Ramon Polo, PharmD, Ph.D., started to work on finding solutions to fight the virus, which data suggested had the potential to become a global pandemic. As the Vice President of Regulatory Affairs for Infectious Diseases and Vaccines and Global Public Health at Johnson & Johnson, Dr. Polo quickly began...
Jul 23, 2020 12:00 PM ET

Pages